U.S. veterans with pulmonary hypertension (PH) due to left heart disease and chronic lung disease are more likely to…
Articles by Marisa Wexler, MS
At-home treatment with inhaled nitric oxide through Genosyl, a tankless delivery system, was used successfully to manage pulmonary…
LIQ861, Liquidia Technology‘s investigational inhaled formulation of treprostinil, is safe and well-tolerated in…
The Pulmonary Hypertension Association (PHA) will be participating in a fundraiser for World PH Day on May 5.
Reata Pharmaceuticals is stopping clinical trials evaluating bardoxolone methyl in people with pulmonary arterial hypertension (PAH), including…
The first person with coronavirus disease 2019 (COVID-19) complicating pulmonary hypertension (PH) has received at-home treatment with inhaled…
Treatment with Orenitram (oral treprostinil) is associated with lower healthcare-related costs than treatment with Uptravi (selexipag) in people…
Among people with chronic thromboembolic pulmonary hypertension (CTEPH), certain anticoagulants may reduce the risk of serious bleeding more than…
Bellerophon Therapeutics has reached an agreement with the U.S. Food and Drug Administration (FDA) setting the design of…
Use of Bellerophon Therapeutics’ INOpulse device — which provides nitric…
Vitamin C deficiency can cause pulmonary arterial hypertension (PAH), a new case report suggests, highlighting the need to test…
Treatment with sotatercept (ACE-011) eased heart strain and improved exercise capacity in individuals with…